---
title: Letter to the Editor Regarding 'Tafamidis 61 mg Patient Characteristics and
  Persistency? A Retrospective Analysis of German Statutory Health Insurance Data
  (IQVIA™ LRx)'
date: '2024-10-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39441481/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241023210141&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...